Surgical treatment of pancreatic endocrine neoplasms

被引:21
作者
Gomez-Rivera, Fernando
Stewart, Ashley E.
Arnoletti, J. Pablo
Vickers, Selwyn
Bland, Kirby I.
Heslin, Martin J.
机构
[1] Univ Alabama, Dept Surg, Sect Surg Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Surg, Sect Gastrointestinal Surg, Birmingham, AL 35294 USA
关键词
pancreatic endocrine neoplasm; insulinoma; gastrinoma;
D O I
10.1016/j.amjsurg.2006.10.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Pancreatic endocrine neoplasia (PEN) is an entity with an indolent course and prolonged survival. The aim of the current study was to review the prognostic factors and outcome of patients with PEN at 1 institution. Methods: Records of patients with the diagnosis of PEN in the period of 1980 to 2001 were reviewed. Descriptive statistics and log-rank test were used; significance was defined as P <.05. Results: Of 49 patients, 25 had functional and 24 nonfunctional tumors. Surgery was performed in 43 patients, 36 with curative intent. With a median follow-up of 31 months, there were 5 deaths. Symptoms were controlled with surgical resection in 86%. Median disease-free survival (DFS) was 46 months; actuarial 5-year disease-specific (DSS) was 72%. Factors associated with better DFS and DSS were absence of liver involvement (P =.02) and resection of the primary tumor (P =.04). Conclusions: Surgical resection and absence of liver metastases are associated with better DFS and DSS in patients with PEN. (c) 2007 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:460 / 465
页数:6
相关论文
共 19 条
[1]   The surgical management of pancreatic neuroendocrine tumors [J].
Azimuddin, K ;
Chamberlain, RS .
SURGICAL CLINICS OF NORTH AMERICA, 2001, 81 (03) :511-+
[2]   Hepatic neuroendocrine metastases: Does intervention alter outcomes? [J].
Chamberlain, RS ;
Canes, D ;
Brown, KT ;
Saltz, L ;
Jarnagin, W ;
Fong, YM ;
Blumgart, LH .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 190 (04) :432-445
[3]   Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas [J].
Chu, QD ;
Hill, HC ;
Douglass, HO ;
Driscoll, D ;
Smith, JL ;
Nava, HR ;
Gibbs, JF .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) :855-862
[4]  
ECKHAUSER FE, 1986, SURGERY, V100, P978
[5]   CLINICAL CHARACTERISTICS, TREATMENT AND SURVIVAL IN PATIENTS WITH PANCREATIC TUMORS CAUSING HORMONAL SYNDROMES [J].
GRAMA, D ;
ERIKSSON, B ;
MARTENSSON, H ;
CEDERMARK, B ;
AHREN, B ;
KRISTOFFERSSON, A ;
RASTAD, J ;
OBERG, K ;
AKERSTROM, G .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :632-639
[6]  
LEGASPI A, 1988, SURGERY, V104, P1018
[7]  
Liang H, 2004, WORLD J GASTROENTERO, V10, P1806
[8]   Islet cell carcinoma of the pancreas [J].
Lo, CY ;
vanHeerden, JA ;
Thompson, GB ;
Grant, CS ;
Soreide, JA ;
Harmsen, WS .
WORLD JOURNAL OF SURGERY, 1996, 20 (07) :878-884
[9]   Prognostic factors in patients with endocrine tumours of the duodenopancreatic area [J].
Madeira, I ;
Terris, B ;
Voss, M ;
Denys, A ;
Sauvanet, A ;
Flejou, JF ;
Vilgrain, V ;
Belghiti, J ;
Bernades, P ;
Ruszniewski, P .
GUT, 1998, 43 (03) :422-427
[10]  
Matthews BD, 2002, AM SURGEON, V68, P660